Patient Power video - Dr Susan O’Brian on B-Ce... - CLL Support

CLL Support

22,475 members38,615 posts

Patient Power video - Dr Susan O’Brian on B-Cell Receptor Agents from The 9th European Congress on Hematologic Malignancies

HAIRBEAR_UK profile image
HAIRBEAR_UKFounder Admin
0 Replies

The latest news video from Andrew Schorr and Patient Power from the 9th European Congress on Hematologic Malignancies in Lyon, France: Is with Dr Susan O’Brian as she shares her views on B-cell receptor Agents. The inhibitors much discussed in earlier broadcasts from over the pond at ASH.

"What are B-cell receptor agents? How can they help in chronic lymphocytic leukemia (CLL) treatment? There are several new drugs, B-cell receptor agents, now in clinical trials. Could they be the start of a new age in the treatment of CLL?"

patientpower.info/video/b-c...

I hope Andrew Schorr was able to capture interviews with the Leading UK/European CLL speakers too.Will keep my eyes peeled.

Session III: Chronic Lymphocytic Leukemia I

Moderator: Eva Kimby, MD, PhD

9:05 Genomic abnormalities in CLL

Anna Schuh, MD, PhD

9:25 Optimal frontline management of CLL patients

Susan O’Brien, MD

9:45 Optimal frontline therapy for the high risk patient (17p deletion)

Peter Hillmen, MD

10:05 What is the role of transplantation today in CLL? Peter Dreger, MD

Session IV: Chronic Lymphocytic Leukemia II

Moderator: Susan O’Brien, MD

11:00 Treatment of the elderly patient with CLL

Barbara Eichhorst, MD

11:20 Management of the relapsed/refractory patient

Claire Dearden, MD

11:40 BTK inhibition in CLL

Susan O’Brien, MD

imedex.com/hematologic-mali...

Happy Easter :-)

Written by
HAIRBEAR_UK profile image
HAIRBEAR_UK
Founder Admin
To view profiles and participate in discussions please or .
Read more about...

You may also like...

Zanubrutinib vs. Ibrutinib Patient Power Video by Dr. Jennifer Brown MD PHD

Dana Farber, updates our chronic lymphocytic leukemia (CLL) patients on the latest from the 2022...

Imbruvica adverse effects.

com/insights/b-cell-malignancies/adverse-events-of-ibrutinib-in-chronic-lymphocytic-leukemia

Dr. O'Brien on how she treats CLL frontline and Dr. Pagel on new ways to block BTK

option for her CLL patients....

The current status and challenges of CAR-T therapy in CLL

patients with chronic lymphocytic leukemia (CLL).\\" It's a Podcast, so like listening to a...

News about V+O and Acalabrutinib from EHA

org/2019/11/eha-2019-dr-peter-hillman-on-venetoclax-and-obinutuzumab-in-cll-chronic-lymphocytic-leuk